Thompson, IM; Ankerst, DP; Chi, C; Lucia, MS; Goodman, P; Crowley, JJ; Parnes, HL; Coltman Jr., CA
The operating characteristics of prostate-specific antigen in a population with initial PSA of 3.0 ng/ml or lower
Journal of the American Medical Association
2005
294
1
66-70

Hayden, D; Pauler, DK; Schoenfeld, D
An estimator for treatment comparisons among survivors in randomized trials
Biometrics
2005
61
305-310

Hansen, LK; Feigl, P; Modiano, MR; Lopez, JA; Escobedo Sluder, S; Moinpour, CM; Pauler, DK; Meyskens, FL
And educational program to increase cervical and breast cancer screening in Hispanic women: A Southwest Oncology Group Study
Cancer Nursing
2005
28
1
47-53

Maecker, H. T.;Moon, J.;Bhatia, S.;Ghanekar, S. A.;Maino, V. C.;Payne, J. K.;Kuus-Reichel, K.;Chang, J. C.;Summers, A.;Clay, T. M.;Morse, M. A.;Lyerly, H. K.;DeLaRosa, C.;Ankerst, D. P.;Disis, M. L.
Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOT
BMC Immunology
2005
6
1
17

Etzioni, R. D.;Howlader, N.;Shaw, P. A.;Ankerst, D. P.;Penson, D. F.;Goodman, P. J.;Thompson, I. M.
Long-term effects of finasteride on prostate specific antigen levels: results from the prostate cancer prevention trial
Journal of Urology
2005
174
3
Sep
877--881